BioCorRx Inc. (OTCQB: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program developed by BioCorRx Inc. is a proprietary counseling program (plus peer support program) specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The Company also has an R&D subsidiary, BioCorRx Pharmaceuticals, which is currently developing a new injectable naltrexone technology (BICX101) through a partnership with TheraKine Ltd. The company plans to seek FDA approval for BICX101 and/or its naltrexone implant product(s). For more information on BICX, visit www.BioCorRx.com.
The BioCorRx® Recovery Program consists of two main components:
- BioCorRx® has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant compound of the FDA-approved drug naltrexone. After being surgically implanted by a medical professional, the naltrexone in the implant can significantly reduce cravings and some effects of alcohol and opioid use for several months in many individuals, depending on individual metabolism rates and other factors. Furthermore, once the implant has dissolved, a vast majority of program participants are pleased to discover that their physical cravings for alcohol continue to remain greatly reduced or even eliminated.
- BioCorRx® also created a counseling program written by addiction experts that is tailored specifically to substance abuse addicts receiving long term naltrexone treatment. Once a participant has received the implant, they are encouraged to enter the counseling portion of the program to maximize results.
BioCorRx’s revolutionary program has a tremendous success rate as reported by the independently owned and operated centers using the program. The implant is administered as an outpatient procedure, and in most cases, individuals do not need to miss more than one day of work. They are then able to enter the outpatient counseling portion of the program in complete privacy if they so choose.